OPUS GENETICS
Live / Applied — Fifth extension granted (statement of use) (as of 29 Jan 2026)
What this means for you
Not registered yet, but its 21 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97276819
- Mark type
- Stylized text
- Filed
- 21 Feb 2022
- Published for opposition
- 17 Jan 2023
- Attorney of record
- Dusan Clark
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and biologic preparations for the diagnosis and treatment of retinal and ocular diseases; pharmaceutical and biologic preparations for human use for the treatment of retinal and ocular diseases through gene therapy
Owner
- Opus Genetics, Inc., Durham, NC, US
- Opus Genetics, Inc., Raleigh, NC, US
Prosecution history
- 30 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2026 — SOU EXTENSION 5 GRANTED
- 10 Sept 2025 — SOU EXTENSION 5 FILED
- 29 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2025 — SOU EXTENSION 4 GRANTED
- 18 Feb 2025 — SOU EXTENSION 4 FILED
- 18 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Jan 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Jan 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED